1158Significance of HIV Viral Load and CD4 Count on Kaposi Sarcoma in the Era of Highly-Active-Antiretroviral Therapy

Abstract

. Approximately 20% of patients with HIV will have Kaposi Sarcoma (KS) and about half will die within 3 months of diagnosis. Incidence and outcomes of KS have traditionally been linked to CD4 counts <350. More recently, KS has been increasingly described in higher CD4 counts and variable presentations in the era of HighlyActive-Antiretroviral-Therapy (HAART). No studies have established the role of Viral Load (VL) on KS.